Related Experiment Video
Updated: Jul 6, 2026
12:45
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
What is cardiac resynchronisation therapy and who will benefit?
Aparna Jaswal1, J Singh, M A Dar
1Department of Cardiac Pacing and Electrophysiology, Escorts Heart Instt. and Research Centre, Okhla Road, New Delhi.
The Journal of the Association of Physicians of India
|March 29, 2008
Summary
Cardiac Resynchronisation Therapy (CRT) improves outcomes for severe heart failure patients. Ongoing research, including Tissue Doppler Imaging (TDI), aims to enhance CRT effectiveness by identifying more suitable candidates.
Area of Science:
- Cardiology
- Medical Technology
Background:
- Cardiac Resynchronisation Therapy (CRT) is a proven treatment for end-stage heart failure.
- Large randomized trials support CRT's benefits in improving symptoms, exercise capacity, quality of life, and survival.
- Despite its efficacy, some patients do not respond to CRT.
Purpose of the Study:
- To explore methods for improving Cardiac Resynchronisation Therapy (CRT) responder rates.
- To identify patients who may benefit from CRT beyond conventional indications.
- To highlight the role of Tissue Doppler Imaging (TDI) in patient selection for CRT.
Main Methods:
- Review of data from large randomized trials on Cardiac Resynchronisation Therapy (CRT).
- Discussion of ongoing research into novel patient selection strategies.
- Emphasis on the application of Tissue Doppler Imaging (TDI) techniques.
Main Results:
- CRT significantly improves clinical outcomes and survival in severe systolic heart failure.
- A subset of patients are identified as non-responders to CRT.
- Tissue Doppler Imaging (TDI) shows promise in identifying CRT candidates.
Conclusions:
- Cardiac Resynchronisation Therapy (CRT) is a valuable intervention for severe heart failure.
- Further research is needed to optimize patient selection and improve CRT response rates.
- Tissue Doppler Imaging (TDI) is emerging as a key tool for enhancing CRT efficacy.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:23Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.